Next Article in Journal
A cross-sectional survey of urinary iodine status in Latvia
Previous Article in Journal
The importance of MTHFR C677T/A1298C combined polymorphisms in pulmonary embolism in Turkish population
Medicina is published by MDPI from Volume 54 Issue 1 (2018). Articles in this Issue were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence. Articles are hosted by MDPI on as a courtesy and upon agreement with Lithuanian Medical Association, Lithuanian University of Health Sciences, and Vilnius University.
Open AccessArticle

Evaluation of atrial fibrillation management and cardiovascular risk profile in atrial fibrillation patients: A cross-sectional survey

Centre for Cardiology and Angiology, Department of Cardiovascular Diseases, Vilnius University, Vilnius, Lithuania
Department of Cardiology, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Medicina 2017, 53(1), 19-25;
Received: 20 July 2015 / Revised: 25 January 2017 / Accepted: 26 January 2017 / Published: 20 February 2017
Objective: The aim of this study to investigate the most frequent risk factors of atrial fibrilla- tion (AF), co-morbidities, complications associated with AF and the use of anticoagulants and other medications in patients who were referred to university hospitals in Lithuania.Materials and methods: This cross-sectional study enrolled consecutive inpatients and outpatients with AF presenting to cardiologists in the two biggest Lithuanian university hospitals from November 2013 to May 2014. AF diagnosis was confirmed by a 12-lead ECG or 24-h Holter with an episode duration of >30 s.Results: A total number of 575 patients were recruited, and complete data on clinical subtype were available for 515 patients (mean age of 70.7 years; 48.5% of women). Permanent AF was the most frequent type of AF (46.6%). Common comorbidities were hypertension (85.8%), heart failure (77.9%) and coronary artery disease (51.8%). Amiodarone was the most common antiarrhythmic agent used in 14.6% of the patients, while beta-blockers and digoxin were the most often used rate control drugs (59.6% and 10.7%, respectively). Oral anticoagulants were used by 53.3% of the patients; of them, 95.6% used vitamin K antagonists, while non-vitamin K antagonist were used by only 4.4%. The INR within a therapeutic range (2.0–3.0) was documented in 19.2% of the patients. Other antithrombotic drugs such as aspirin and clopidogrel were used in 13.7% and 2.0% of the patients, respectively; dual antiplatelet treatment was administered in 6.2% of the patients. Of the entire cohort, the mean CHA2DS2-VASc score was 3.97 ± 1.6 and the mean HAS-BLED score was 2.25 ± 1.0.Conclusions: Compliance with the treatment guidelines remains suboptimal and further patient education is needed.
Keywords: Atrial fibrillation; Risk scores; Anticoagulation Atrial fibrillation; Risk scores; Anticoagulation
MDPI and ACS Style

Račkauskas, G.; Zabiela, V.; Marinskis, G.; Baranauskas, A.; Balkutė, D.; Alunderytė, J.; Puodžiūkynas, A.; Kazakevičius, T.; Kviesulaitis, V.; Aidietis, A. Evaluation of atrial fibrillation management and cardiovascular risk profile in atrial fibrillation patients: A cross-sectional survey. Medicina 2017, 53, 19-25.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

Back to TopTop